Be part of the knowledge.™

In the Pink? Examining Breast Cancer Awareness Campaigns

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Pink ribbon campaigns have been highly successful in rallying recognition and funding around breast cancer. But our guest thinks the cheerful image of such campaigns whitewashes realities of the disease, both in terms of statistics and patient experiences. Plus: Warnings about the drug cocktail known as “bath salts,” and a novel innovation for biomarking GI ailments with color.

Gayle Sulik, PhD

Gayle Sulik, PhD

Matt Birnholz, MD

Matt Birnholz, MD

Michael Greenberg, MD

Michael Greenberg, MD

Recommended

Details

Presenters

Overview
Pink ribbon campaigns have been highly successful in rallying recognition and funding around breast cancer. But our guest thinks the cheerful image of such campaigns whitewashes realities of the disease, both in terms of statistics and patient experiences. Plus: Warnings about the drug cocktail known as “bath salts,” and a novel innovation for biomarking GI ailments with color.

Gayle Sulik, PhD

Gayle Sulik, PhD

Matt Birnholz, MD

Matt Birnholz, MD

Michael Greenberg, MD

Michael Greenberg, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

$IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement$

IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

HF Management for Patients with Comorbid Conditions

Level Up Your Skills: Tailoring Management of HF

Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

Second-line Chemotherapy Options in Metastatic PDAC